home *** CD-ROM | disk | FTP | other *** search
- Newsgroups: alt.drugs
- Path: sparky!uunet!usc!zaphod.mps.ohio-state.edu!rpi!usenet.coe.montana.edu!news.u.washington.edu!stein.u.washington.edu!lamontg
- From: lamontg@stein.u.washington.edu (Lamont Granquist)
- Subject: Re: MPTP (was Re: MDMA and self-esteem)
- Message-ID: <1992Dec23.073154.15839@u.washington.edu>
- Sender: news@u.washington.edu (USENET News System)
- Organization: 'Operation: Mindcrime'
- References: <1992Dec9.040016.19908@netcom.com> <1992Dec14.043227.25332@ne <1992Dec15.155012.10012@mnemosyne.cs.du.edu> <1992Dec18.221614.12434@midway.uchicago.edu>
- Date: Wed, 23 Dec 1992 07:31:54 GMT
- Lines: 19
-
- bagg@ellis.uchicago.edu (matthew john baggott) writes:
- >What reason do we have to think that MPTP doesn't have opiate-like effects?
- >I don't know, but perhaps that would explain why some users ended up with
- >parkinson's while others didn't (those who did get the syndrome injected
- >multiple times). Another explanation would be dosage differences, of course.
- >
- >And wasn't MPTP a contaminent in meperidine/pethidine itself?
-
- MPTP is produced by a synthetic error in making MPPP, which is an opiate
- whose chemical formula I don't seem to have on hand. From what I read on
- it, it sounded like there were large quantities of MPTP in the batches
- consumed and that it wasn't just a "contaminant". The implication seemed
- to be that the users thought it was a new kind of opiate. However, I
- didn't track this back to the original articles...
-
- --
- Lamont Granquist lamontg@u.washington.edu
- "When dogma enters the brain, all intellectual activity ceases."
- -- Robert Anton Wilson
-